The Wellbeing Neuro Course: Comparing clinician-guided versus self-guided online mental health care for adults with epilepsy

Not Applicable

Recruiting

• Conditions: Epilepsy; Depression; Anxiety; Neurological - Epilepsy; Mental Health - Anxiety; Mental Health - Depression

• Registration Number: ACTRN12623001327673
• Lead Sponsor: Dr. Milena Gandy

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-12-19
• Last Update Posted: 8 April 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 375

Inclusion Criteria

(1) Confirmed diagnosis of epilepsy.
(2) Experiencing difficulties with their emotional health.
(3) 18+ years of age.
(4) Living in Australia.

Exclusion Criteria

(1) Imminently suicidal or unable to keep themselves safe.
(2) Are experiencing severe cognitive difficulties with day-to-day memory, attention and ability to learn basic information.
(3) Are unable to read and understand English.
(4) Do not have access to the internet.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Patient Health Questionnaire 9-Item (PHQ-9), a measure of depressive symptoms.[ Assessment<br>Baseline (pre-intervention)<br>The PHQ-2 will be administered weekly for 9 weeks throughout the intervention period <br>11 weeks (post-intervention/ primary endpoint)<br>3-months post-intervention completion<br>12-months post-intervention completion];Generalized Anxiety Disorder 7-Item (GAD-7), a measure of anxiety symptoms.[ Assessment <br>Baseline (pre-intervention)<br>The GAD 2-Item will be administered weekly for 9 weeks throughout the intervention period<br>11 weeks (post-intervention/primary endpoint)<br>3-months post-intervention completion<br>12-months post-intervention completion]